Michael Starck

Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation

Nicola Gökbuget, Daniel Stanze, Joachim Beck et al. · Blood · 2012 · 451 citations · Full text

Moderate Intensive Chemotherapy Including CNS-Prophylaxis with Liposomal Cytarabine Is Feasible and effective in Older Patients with Ph-Negative Acute Lymphoblastic Leukemia (ALL): Results of a Prospective Trial From the German Multicenter Study Group for Adult ALL (GMALL)

Nicola Goekbuget, Joachim Beck, Monika Brüggemann et al. · Blood · 2012 · 76 citations

Significant Improvement Of Outcome In Adolescents and Young adults (AYAs) Aged 15-35 Years With Acute Lymphoblastic Leukemia (ALL) With a Pediatric Derived Adult ALL Protocol; Results Of 1529 AYAs In 2 Consecutive Trials Of The German Multicenter Study Group For Adult ALL (GMALL)

Nicola Gökbuget, Joachim Beck, Kalina Brandt et al. · Blood · 2013 · 52 citations

Prognostic model for newly diagnosed CLL patients in Binet stage A: results of the multicenter, prospective CLL1 trial of the German CLL study group

Manuela A. Hoechstetter, Raymonde Busch, Barbara Eichhorst et al. · Leukemia · 2020 · 37 citations

Hematological Malignancy, Prognostic Evaluation, Prospective Cll1 Trial +8

Loss-of-function but not dominant-negative intragenic <i>IKZF1</i> deletions are associated with an adverse prognosis in adult <i>BCR-ABL</i> -negative acute lymphoblastic leukemia

Benjamin Kobitzsch, Nicola Gökbuget, Stefan Schwartz et al. · Haematologica · 2017 · 29 citations · Full text